Literature DB >> 3829306

Delayed digoxin toxicity following discontinuance in acute renal failure.

A M Ho, I M Fraser, D D Suria.   

Abstract

A digitalized 75-year-old patient with postoperative renal failure demonstrated a progressive rise in serum digoxin concentration, peaking at 3.4 nmol X L-1 three days following discontinuance of the drug. This was accompanied by cardiac bradyarrhythmias. Although the serum digoxin concentration had already started to climb from a therapeutic level prior to the discontinuance of the drug, the unabated and substantial rise was consistent with a dramatic decrease in the apparent volume of distribution of digoxin accompanying acute renal failure. Serum digoxin levels were determined with fluorescence polarization immunoassay, which has an improved specificity when compared to the commonly used radioimmunoassays for digoxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829306     DOI: 10.1007/bf03015342

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

Authors:  R H Reuning; R A Sams; R E Notari
Journal:  J Clin Pharmacol New Drugs       Date:  1973-04

2.  Digoxin-like immunoreactivity in the serum of neonates and uremic patients, as measured in the Abbott TDX.

Authors:  R W Yatscoff; P R Desjardins; J G Dalton
Journal:  Clin Chem       Date:  1984-04       Impact factor: 8.327

3.  An endogenous digoxin-like substance and renal failure.

Authors:  V J Heazlewood; R L Heazlewood; L B Jellett
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

4.  Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.

Authors:  L F Ferreri; V A Raisys; K E Opheim
Journal:  J Anal Toxicol       Date:  1984 May-Jun       Impact factor: 3.367

5.  Verapamil-digoxin interaction.

Authors:  H O Klein; R Lang; E Di Segni; E Kaplinsky
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

Review 6.  Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.

Authors:  R Valdes
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

7.  An endogenous digoxin-like substance in patients with renal impairment.

Authors:  S W Graves; B Brown; R Valdes
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

8.  Rising serum digoxin without further dosage in acute renal failure.

Authors:  M H Gault; B Gallway; A Fine; S Vasdev
Journal:  Nephron       Date:  1984       Impact factor: 2.847

9.  Biotransformation and elimination of digoxin with normal and minimal renal function.

Authors:  M H Gault; D Sugden; C Maloney; M Ahmed; M Tweeddale
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

Review 10.  Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.

Authors:  T W Smith
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.